Invesco
ARQT icon

Invesco’s Arcutis Biotherapeutics ARQT Stock Holding History

Invesco’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.29M Sell
139,843
-167,539
-55% -$4.28M ﹤0.01% 2337
2025
Q4 		$8.93M Buy
307,382
+114,430
+59% +$2.93M ﹤0.01% 1917
2025
Q3 		$3.64M Buy
192,952
+93,249
+94% +$1.47M ﹤0.01% 2372
2025
Q2 		$1.4M Sell
99,703
-1,229,251
-92% -$17.2M ﹤0.01% 2721
2025
Q1 		$20.8M Buy
1,328,954
+202,286
+18% +$2.85M ﹤0.01% 1420
2024
Q4 		$15.7M Buy
1,126,668
+188,184
+20% +$2.06M ﹤0.01% 1609
2024
Q3 		$8.73M Buy
938,484
+890
+0.1% +$8.78K ﹤0.01% 1913
2024
Q2 		$8.72M Buy
937,594
+65,250
+7% +$590K ﹤0.01% 1874
2024
Q1 		$8.64M Buy
872,344
+847,208
+3,370% +$6.32M ﹤0.01% 1904
2023
Q4 		$81.2K Buy
25,136
+63
+0.3% +$171 ﹤0.01% 3708
2023
Q3 		$133K Sell
25,073
-246
-1% -$2.09K ﹤0.01% 3681
2023
Q2 		$241K Buy
25,319
+1,289
+5% +$14.3K ﹤0.01% 3564
2023
Q1 		$264K Buy
24,030
+7,195
+43% +$104K ﹤0.01% 3542
2022
Q4 		$249K Sell
16,835
-1,786
-10% -$31.2K ﹤0.01% 3596
2022
Q3 		$356K Sell
18,621
-190,554
-91% -$4.32M ﹤0.01% 3436
2022
Q2 		$4.46M Buy
209,175
+197,916
+1,758% +$4.06M ﹤0.01% 2348
2022
Q1 		$217K Buy
11,259
+199
+2% +$3.37K ﹤0.01% 3757
2021
Q4 		$229K Sell
11,060
-2,054
-16% -$40.9K ﹤0.01% 3728
2021
Q3 		$314K Buy
13,114
+1,029
+9% +$23.5K ﹤0.01% 3635
2021
Q2 		$331K Buy
+12,085
New +$340K ﹤0.01% 3589

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return